{"database":"biostudies-other","file_versions":[],"scores":null,"additional":{"submitter":["Correnti JM"],"funding":["NIDDK NIH HHS","NIAAA NIH HHS"],"pagination":["12923"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6110824"],"abstract":["Obesogenic lipids and the sphingolipid ceramide have been implicated as potential cofactors in alcoholic liver disease (ALD) patients. However, the mechanisms by which these lipids modulate lipid trafficking in ethanol-treated human liver cells to promote steatosis, an early stage of ALD, are poorly understood. We measured fatty acid (FA) uptake, triglyceride export, FA synthesis and FA oxidation in human hepatoma (VL-17A) cells in response to ethanol and the exogenous lipids oleate, palmitate and C2 ceramide. We found that in combination with ethanol, both oleate and palmitate promote lipid droplet accumulation while C2 ceramide inhibits lipid droplet accumulation by enhancing FA oxidation. Further, using both a pharmacologic and siRNA approach to reduce peroxisome proliferator-activated receptors ? (PPAR?) gene expression, we demonstrate that C2 ceramide abrogates ethanol-mediated suppression of FA oxidation through an indirect PPAR? mechanism. Together, these data suggest that lipids interact differentially with ethanol to modulate hepatocellular lipid droplet accumulation and may provide novel targets for preventing the earliest stage of alcoholic liver disease, alcoholic steatosis."],"repository":["biostudies-other"],"data_source":["Europe PMC"],"omics_type":["Unknown"],"volume":["8(1)"],"journal":["Scientific reports"],"pmcid":["PMC6110824"],"funding_grant_id":["F32 AA024347","T32 DK007066","P30 DK019525","R01 AA026302","K08 AA021424","P30 DK050306"],"pubmed_authors":["Lin A","Bennett MJ","Chen J","Correnti JM","Beck J","Oranu A","Gottshall L","Williams B","Carr RM"],"additional_accession":[]},"is_claimable":false,"name":"Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells.","description":"Obesogenic lipids and the sphingolipid ceramide have been implicated as potential cofactors in alcoholic liver disease (ALD) patients. However, the mechanisms by which these lipids modulate lipid trafficking in ethanol-treated human liver cells to promote steatosis, an early stage of ALD, are poorly understood. We measured fatty acid (FA) uptake, triglyceride export, FA synthesis and FA oxidation in human hepatoma (VL-17A) cells in response to ethanol and the exogenous lipids oleate, palmitate and C2 ceramide. We found that in combination with ethanol, both oleate and palmitate promote lipid droplet accumulation while C2 ceramide inhibits lipid droplet accumulation by enhancing FA oxidation. Further, using both a pharmacologic and siRNA approach to reduce peroxisome proliferator-activated receptors ? (PPAR?) gene expression, we demonstrate that C2 ceramide abrogates ethanol-mediated suppression of FA oxidation through an indirect PPAR? mechanism. Together, these data suggest that lipids interact differentially with ethanol to modulate hepatocellular lipid droplet accumulation and may provide novel targets for preventing the earliest stage of alcoholic liver disease, alcoholic steatosis.","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Aug","modification":"2019-03-26T23:53:41Z","creation":"2019-03-26T23:53:41Z"},"accession":"S-EPMC6110824","cross_references":{"pubmed":["30150688"],"doi":["10.1038/s41598-018-31025-0 "]}}